Osteoporosis Market Research Reports & Industry Analysis
Osteoporosis is characterized by decreased bone mineral density (BMD) and deterioration of the bone microarchitecture, a combination of factors that lead to an increased risk of fracture. Osteoporosis affects hundreds of millions of people worldwide, in developed and undeveloped nations. The prevalence of osteoporosis is projected to increase considerably as the global population ages and life expectancy increases as anticipated. The Office of the Surgeon General in the U.S. warns that osteoporosis may become an epidemic if people do not make the adjustments in nutrition, supplementation, and physical activity necessary to prevent osteoporosis.
The overall cost of osteoporosis fractures and their complications poses a considerable burden for healthcare systems around the world; osteoporosis costs are comparable with those of other major chronic diseases, such as cardiovascular diseases and asthma. In addition, osteoporosis fractures are a major cause of disability and morbidity among older people; an estimated fifth of patients who experience an osteoporotic hip fracture die due to complications within 1 year after the fracture. Drug therapies that are capable of addressing osteoporosis and reducing the risk of fractures could bring economic benefits to governments and healthcare providers and improve the quality of life for osteoporosis patients.
Osteoporosis Industry Research & Market Reports
-
Osteoporosis Drugs Global Market Opportunities And Strategies To 2034
... it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market is being affected by ... Read More
-
Osteoporosis Drugs Markets in China
... which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply ... Read More
-
Osteoporosis Drugs Industry Forecasts - China Focus
... China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for ... Read More
-
Osteoporosis Drugs Companies in China
... consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest ... Read More
-
Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2025-2033
... increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market. Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular ... Read More
-
Global Osteoporosis Testing Market - 2022-2029
... expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030). With mergers, acquisitions, and product launches, the global osteoporosis testing market is moderately competitive. Some of the key players in the market are ... Read More
-
Global Raloxifene Hydrochloride Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Viscosupplementation Market, By Dosage (Single Injection, Three Injection, and Five Injection), By Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the ... Read More
-
Hyaluronic Acid
... CAGR of 8.1% over the analysis period 2024-2030. Offline Distribution Channel, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Bone Densitometers
... CAGR of 5.6% over the analysis period 2024-2030. Axial Bone Densitometers, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$264.5 Million by the end of the ... Read More
-
Osteoporosis_Global Clinical Trials Review, 2025
... trials on Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), ... Read More
-
Women's Health Market Report by Age Group Type (50 Years and Above, and Others), Application (Contraceptives, Osteoporosis, Menopause, Infertility, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
... health market size reached USD 42.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 59.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.59% during 2025-2033. The growing population ... Read More
-
Global Women's Healthcare Market Size study, by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Premarin, Actonel) by Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause), and Regional Forecasts 2022-2032
... Market, valued at approximately USD 29.23 billion in 2023, is forecasted to expand at an impressive compound annual growth rate (CAGR) of 13.20% from 2024 to 2032, reaching an estimated USD 89.22 billion by the ... Read More
-
Bone Mineral Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... to a readjusted size of US$ 1,774.10 million by 2030 with a CAGR of 9.51% during the forecast period 2024-2030. North American market for Bone Mineral Testing was valued at $ 393.78 million in 2023 ... Read More
-
DEXA Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... million by the end of 2030, growing at a CAGR of 4.18% during 2024-2030. In this study, the consumption market for DEXA Devices was divided into five geographic regions. North America occupied the largest consumption ... Read More
-
U.S. Women’s Health Market Size, Share & Trends Analysis Report By Application (Postmenopausal Osteoporosis, Infertility, Contraceptives, Menopause, PCOS), By Age, By Drug Class, And Segment Forecasts, 2025 - 2030
... & Trends The global dry eye syndrome treatment market size is estimated to reach USD 9.20 billion by 2030, expanding at a CAGR of 6.5% from 2025 to 2030, according to a new report by ... Read More
-
Zilosul Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... yields glucurono-xylans, which are then sulfated to create a negatively charged substance that resembles glycosaminoglycans (GAGs). GAGs are complex carbohydrates that interact with proteins involved in inflammatory processes, thereby regulating various bodily functions. PPS is ... Read More
-
X0002 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... (OA) and rheumatoid arthritis. This novel drug is being evaluated for its effectiveness in delivering pain relief and anti-inflammatory effects directly through the skin. A Phase III clinical trial, TF-X0002-31 (Freedom-1), has been initiated at ... Read More
-
Wegovy Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... reducing food consumption, and lowering calorie intake. Semaglutide has received approval from the US FDA for long-term weight management in adults who are obese or overweight with at least one weight-related condition, such as hypertension, ... Read More
-
Tlc599 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... relief. TLC599 offers the benefit of locally delivering a powerful, clinically validated steroid that typically has a short half-life, providing both immediate and sustained effects. This emerging therapy presents several advantages, including rapid pain relief, ... Read More
-
Sprifermin Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... It is administered through injections directly into the joint, typically every 6 to 12 months. Notably, sprifermin is the first recombinant form of FGF18 shown to promote cartilage growth in a controlled clinical trial, positioning ... Read More
-
Rtx-grt7039 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... Potential Vanilloid 1 (TRPV1) receptor operates through a well-established mechanism and is administered directly into the joint via intra-articular injection. As osteoarthritis patients increasingly seek effective alternatives to traditional osteoarthritis treatments, RTX-GRT7039 offers a promising ... Read More
-
Renu Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... the fetus and acting as a barrier between mother and baby. Amniotic tissue has been used in medical treatments for over a century due to its healing properties. ReNu is rich in anti-inflammatory cytokines, regenerative ... Read More
-
Mm-ii Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... multilamellar liposomes alongside an innovative mechanism of action to deliver long-lasting symptomatic relief. Extensive pre-clinical research has confirmed the safety and lubricating effects of MM-II, which help to minimize joint friction and cartilage wear. Additionally, ... Read More
-
Lorecivivint Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... (DMOAD). Preclinical studies with vehicle-controlled models suggest that lorecivivint may act through a dual mechanism, providing three key benefits for joint health: promoting cartilage regeneration, slowing cartilage degradation, and reducing inflammation. These effects are increasingly ... Read More
Research Assistance
